JP2024503894A5 - - Google Patents
Info
- Publication number
- JP2024503894A5 JP2024503894A5 JP2023544048A JP2023544048A JP2024503894A5 JP 2024503894 A5 JP2024503894 A5 JP 2024503894A5 JP 2023544048 A JP2023544048 A JP 2023544048A JP 2023544048 A JP2023544048 A JP 2023544048A JP 2024503894 A5 JP2024503894 A5 JP 2024503894A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hpv
- use according
- cancer
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163140159P | 2021-01-21 | 2021-01-21 | |
| US63/140,159 | 2021-01-21 | ||
| PCT/US2022/013228 WO2022159652A1 (en) | 2021-01-21 | 2022-01-21 | T cell-directed anti-cancer vaccines against commensal viruses for treating mucosal carcinomas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503894A JP2024503894A (ja) | 2024-01-29 |
| JP2024503894A5 true JP2024503894A5 (cg-RX-API-DMAC7.html) | 2025-01-29 |
Family
ID=82549772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544048A Pending JP2024503894A (ja) | 2021-01-21 | 2022-01-21 | 粘膜がんを治療するための共生ウイルスに対するt細胞誘導性抗がんワクチン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240100141A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4281106A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024503894A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022159652A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2824326B1 (fr) * | 2001-05-04 | 2004-03-19 | Commissariat Energie Atomique | Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications |
| EP1732598A4 (en) * | 2003-12-31 | 2009-08-26 | Pharmexa Inc | TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| EP2468763B1 (en) * | 2007-05-31 | 2014-06-18 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
| CN113559253B (zh) * | 2007-11-02 | 2024-09-17 | 约翰霍普金斯大学 | 用于治疗或预防人乳头瘤病毒感染的多型hpv肽的组合物和方法 |
| JP7688576B6 (ja) * | 2018-11-28 | 2025-07-04 | ザ ジェネラル ホスピタル コーポレイション | 共生ウイルスに対するt細胞指向性抗がんワクチン |
-
2022
- 2022-01-21 WO PCT/US2022/013228 patent/WO2022159652A1/en not_active Ceased
- 2022-01-21 JP JP2023544048A patent/JP2024503894A/ja active Pending
- 2022-01-21 US US18/273,466 patent/US20240100141A1/en active Pending
- 2022-01-21 EP EP22743214.3A patent/EP4281106A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2253636T3 (es) | Vacuna contra hpv. | |
| JP2025060647A5 (cg-RX-API-DMAC7.html) | ||
| Pearse et al. | ISCOMATRIX® adjuvant for antigen delivery | |
| Garcia-Hernandez et al. | Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine | |
| Davis et al. | DNA vaccines for viral diseases | |
| de la Garza et al. | MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study. | |
| ES2314816T3 (es) | Vacuna contra hbv y hpv. | |
| Sundberg et al. | Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog | |
| JP2022509221A5 (cg-RX-API-DMAC7.html) | ||
| JP5475939B2 (ja) | Hpv−16およびhpv−18l1vlpワクチン | |
| AU2002310802B2 (en) | Multivalent vaccine comprising an HIV antigen and an HSV antigen and/or an HPV antigen | |
| JP2023518340A5 (cg-RX-API-DMAC7.html) | ||
| ES2363247T3 (es) | Tratamiento para neoplasias intraepiteliales anogenitales inducidas por vph. | |
| AU2002310802A1 (en) | Multivalent vaccine comprising an HIV antigen and an HSV antigen and/or an HPV antigen | |
| Huh et al. | The future of vaccines for cervical cancer | |
| JP2008013537A (ja) | Prrsワクチンとしての豚繁殖・呼吸障害症候群ウイルスの融合タンパク質 | |
| Brun et al. | Targeted immunotherapy of high‑grade cervical intra‑epithelial neoplasia: Expectations from clinical trials | |
| CN114681602B (zh) | 一种双价人乳头瘤病毒疫苗 | |
| US8101342B2 (en) | DNA vaccine for treating or preventing cervical cancer comprising a gene encoding HPV protein | |
| JP2008539184A (ja) | ワクチン | |
| Gonçalves et al. | Characterization of immunoglobulin A/G responses during 3 doses of the human papillomavirus-16/18 ASO4-adjuvanted vaccine | |
| Majewski et al. | Vaccination against human papillomavirus (HPV) as primary prophylaxis of cervical cancer and other lesions induced by HPV | |
| Frazer | Cervical cancer vaccine development | |
| JP2005525414A5 (cg-RX-API-DMAC7.html) | ||
| Ault | Virus-like particles as a potential vaccine for human papillomavirus |